Silverback Therapeutics, Inc.·4

Dec 7, 7:55 PM ET

Piazza Jonathan 4

4 · Silverback Therapeutics, Inc. · Filed Dec 7, 2020

Insider Transaction Report

Form 4
Period: 2020-12-03
Piazza Jonathan
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-12-03+74,73074,730 total
    Exercise: $21.00Exp: 2030-12-02Common Stock (74,730 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest in equal monthly installments over the 48 months following December 3, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION